Jean-Marc Le Doussal

Jean-Marc Le Doussal is an accomplished entrepreneur and leader in the biotechnology sector, currently serving as Founder and CEO of Remora Biotech since January 2011, where expertise in immunology is leveraged to develop advanced bio-therapeutics. In addition, Jean-Marc holds founding and chairmanship roles at several companies, including Cellula Therapeutics SA, focused on CAR-T cell development for brain cancer, and OGD2 Pharma, which specializes in anticancer immuno-therapies. Other ventures include Activen SA, dedicated to miniprotein development for the dermo-cosmetic industry, and Fastox Pharma SA, which enhances the performance of botulinum toxins. Formerly associated with ATLAB Pharma SAS and BioTrek Ventures, Jean-Marc has a strong academic background in engineering and immunology, holding multiple degrees from prestigious institutions including École Polytechnique and Aix-Marseille University.